Primary Care-based Resources Can Successfully Address Alcohol-use Problems

Few patients with alcohol-use problems who might benefit from either pharmacotherapy or specialized addiction treatment typically receive care. That may now change owing to a pilot study which examined the feasibility of providing a real-time video consultation resource in primary care. The study’s findings will be shared at the 44th annual scientific meeting of the Research Society on Alcoholism (RSA), which will be held virtually this year from the 19th – 23rd of June 2021 due to the COVID-19 pandemic.

Ibuprofen and other NSAIDs superior to codeine for managing outpatient postoperative pain

Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen provide better pain control and have fewer adverse effects than codeine, a commonly prescribed opioid, when prescribed after outpatient surgery, according to new research published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.201915.

UIC Research Identifies Potential Pathways to Treating Alcohol Use Disorder, Depression

A discovery from researchers at the University of Illinois Chicago may lead to new treatments for individuals who suffer from alcohol use disorder and depression. The study, “Transcriptomics identifies STAT3 as a key regulator of hippocampal gene expression and anhedonia during withdrawal from chronic alcohol exposure,” is published in the journal Translational Psychiatry by researchers at UIC’s Center for Alcohol Research in Epigenetics.

Study: Researchers use eel-like protein to control brain

Newswise imageResearchers successfully used a protein called parapinopsin to turn off brain circuits. This protein is found in lamprey – an ancient lineage of jawless fish similar to eel. Researchers said the ability to inhibit neurons could eventually lead to turning off mood disorders and unwanted behaviors like depression and addiction.